Daniel Betticher

Daniel Betticher

UNVERIFIED PROFILE

Are you Daniel Betticher?   Register this Author

Register author
Daniel Betticher

Daniel Betticher

Publications by authors named "Daniel Betticher"

Are you Daniel Betticher?   Register this Author

59Publications

834Reads

16Profile Views

Swiss Delphi study on iron deficiency.

Swiss Med Wkly 2019 Jul 3;149:w20097. Epub 2019 Jul 3.

Horten Centre for Patient Oriented Research and Knowledge Transfer, University Hospital Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4414/smw.2019.20097DOI Listing
July 2019

[Admission or non admission of patients with cancer to the ICU].

Rev Med Suisse 2019 May;15(649):924-928

Clinique des soins intensifs, HFR Fribourg, Suisse.

View Article

Download full-text PDF

Source
May 2019

Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma.

Bone Marrow Transplant 2018 12 8;53(12):1599-1602. Epub 2018 Jun 8.

Department of Medical Oncology, Inselspital, University Hospital Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41409-018-0245-yDOI Listing
December 2018

Stem cell mobilization chemotherapy with gemcitabine is effective and safe in myeloma patients with bortezomib-induced neurotoxicity.

Leuk Lymphoma 2016 May 12;57(5):1122-9. Epub 2015 Oct 12.

b Department of Medical Oncology , University Hospital of Berne , Berne , Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3109/10428194.2015.1079315DOI Listing
May 2016

BCR-ABL1- positive chronic myeloid leukemia with erythrocytosis presenting as polycythemia vera: a case report.

J Med Case Rep 2015 Apr 8;9:30. Epub 2015 Apr 8.

Hôpital Cantonal Fribourg, Chemin des Pensionnats 2, 1708, Fribourg, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1752-1947-9-30DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506443PMC
April 2015

Cerebral nocardiosis mimicking multiple brain metastases in a patient with locally advanced non-small-cell lung cancer.

J Thorac Oncol 2014 Mar;9(3):e24-6

*Infectious Diseases Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland; †Oncology Department, Fribourg Hospital and Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne; Switzerland; ‡Roswell Park Cancer Institute, Buffalo, New York; §Radiology Department, ‖Microbiology Institute, and ¶Oncology Department, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/JTO.0000000000000018DOI Listing
March 2014

Predictors of venous thromboembolic events associated with central venous port insertion in cancer patients.

J Oncol 2014 9;2014:743181. Epub 2014 Feb 9.

Department of Medical Oncology, Hôpital Cantonal de Fribourg, Chemin des Pensionnats 2, 1700 Fribourg, Switzerland.

View Article

Download full-text PDF

Source
http://www.hindawi.com/journals/jo/2014/743181/
Publisher Site
http://dx.doi.org/10.1155/2014/743181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3934091PMC
March 2014

A phase I/II trial of Tumor Treating Fields (TTFields) therapy in combination with pemetrexed for advanced non-small cell lung cancer.

Lung Cancer 2013 Sep 23;81(3):445-50. Epub 2013 Jul 23.

Medical Oncology, Kantonsspital Winterthur, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2013.06.025DOI Listing
September 2013

A dramatic lung cancer course in a patient with a rare EGFR germline mutation exon 21 V843I: Is EGFR TKI resistance predictable?

Lung Cancer 2013 Apr 4;80(1):81-4. Epub 2013 Feb 4.

HFR Fribourg, Hôpital Cantonal, Department of Internal Medicine, Division of Oncology, Fribourg, Switzerland.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S01695002120063
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2012.11.013DOI Listing
April 2013

The stem cell gene "inhibitor of differentiation 1" (ID1) is frequently expressed in non-small cell lung cancer.

Lung Cancer 2011 Mar 14;71(3):306-11. Epub 2010 Aug 14.

University of Bern, Department Clinical Research, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2010.06.018DOI Listing
March 2011

Trimodality therapy for locally advanced non-small-cell lung cancer: a curative approach.

J Clin Oncol 2011 Feb 4;29(5):e118-9; author reply e120. Epub 2011 Jan 4.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2010.30.1143DOI Listing
February 2011

[Hematuria: which algorithm for an effective diagnostic strategy?].

Rev Med Suisse 2010 Nov;6(271):2173-4, 2176-9

Département de médecine interne, HFR Fribourg, Hôpital cantonal, 1708 Fribourg.

View Article

Download full-text PDF

Source
November 2010

Treatment in resectable, locally advanced NSCLC: which is the best approach?

Expert Rev Respir Med 2008 Oct;2(5):655-61

Cantonal Hospital Fribourg, Department of Internal Medicine and Oncology, CH-1708 Fribourg, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/17476348.2.5.655DOI Listing
October 2008

Heterozygosity of SNP513 in intron 9 of the human calretinin gene (CALB2) is a risk factor for colon cancer.

Anticancer Res 2007 Nov-Dec;27(6C):4279-88

Unit of Anatomy, Department of Medicine, University of Fribourg, Switzerland.

View Article

Download full-text PDF

Source
February 2008

Low prevalence of SV40 in Swiss mesothelioma patients after elimination of false-positive PCR results.

Lung Cancer 2007 Sep 21;57(3):282-91. Epub 2007 May 21.

Clinic and Policlinic of Oncology, Laboratory of Molecular Oncology, University Hospital, Haeldeliweg 4, CH-8044 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016950020700192
Publisher Site
http://dx.doi.org/10.1016/j.lungcan.2007.03.025DOI Listing
September 2007

Cyclin D1 in non-small cell lung cancer: a key driver of malignant transformation.

Lung Cancer 2007 Jan 27;55(1):1-14. Epub 2006 Oct 27.

University of California Davis Cancer Center, Sacramento 95817, USA, and Clinic of Medical Oncology, University Hospital Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.lungcan.2006.09.024DOI Listing
January 2007

Ex vivo assessment of chemotherapy-induced apoptosis and associated molecular changes in patient tumor samples.

Anticancer Res 2006 May-Jun;26(3A):1765-72

Institute of Medical Oncology, University of Bern, Inselspital, Bern, Switzerland.

View Article

Download full-text PDF

Source
August 2006

Clinical proteomics: study of a cryogel.

Proteomics 2006 Jul;6(13):3958-60

Service Régional Vaudois de Transfusion Sanguine, rue du Bugnon 27, 1005 Lausanne, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pmic.200600228DOI Listing
July 2006

Adjuvant and neoadjuvant chemotherapy in NSCLC: a paradigm shift.

Lung Cancer 2005 Dec;50S2:S9-S16

View Article

Download full-text PDF

Source
December 2005

Adjuvant and neoadjuvant chemotherapy in NSCLC: a paradigm shift.

Lung Cancer 2005 Dec;50 Suppl 2:S9-16

Clinic of Medical Oncology, Hospital of Fribourg, Fribourg, Switzerland.

View Article

Download full-text PDF

Source
http://ac.els-cdn.com/S0169500205815685/1-s2.0-S016950020581
Web Search
December 2005

Neoadjuvant treatment of early-stage resectable non-small-cell lung cancer.

Lung Cancer 2004 Dec;46 Suppl 2:S23-32

Institute of Medical Oncology, University of Bern, 3010 Bern, Switzerland.

View Article

Download full-text PDF

Source
December 2004

Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.

J Clin Oncol 2004 Oct;22(20):4157-64

Zurich University Hospital, Clinic and Policlinic of Oncology, Laboratory of Molecular Oncology, Haeldeliweg 4, 8044 Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2004.11.123DOI Listing
October 2004

Maspin - the most commonly-expressed gene of the 18q21.3 serpin cluster in lung cancer - is strongly expressed in preneoplastic bronchial lesions.

Oncogene 2003 Nov;22(54):8677-87

Target Identification Group, Roy Castle International Centre for Lung Cancer Research, University of Liverpool, 200 London Rd, Liverpool L3 9TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207127DOI Listing
November 2003

Comparative multiplex PCR and allele-specific expression analysis in human lung cancer. Tools to facilitate target identification.

Methods Mol Med 2003 ;75:291-304

Roy Castle International Centre for Lung Cancer Research, Liverpool, UK.

View Article

Download full-text PDF

Source
May 2003

Postinduction video-mediastinoscopy is as accurate and safe as video-mediastinoscopy in patients without pretreatment for potentially operable non-small cell lung cancer.

Ann Thorac Surg 2003 Apr;75(4):1102-6

Division of Thoracic Surgery and Institute of Medical Oncology, Inselspital Bern, Bern, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0003-4975(02)04714-8DOI Listing
April 2003

Expression profiling of primary non-small cell lung cancer for target identification.

Oncogene 2002 Oct;21(50):7749-63

Target Identification Group, Roy Castle International Centre for Lung Cancer Research, University of Liverpool, 200 London Road, Liverpool L3 9TA, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1205979DOI Listing
October 2002

Intensive chemotherapy with whole blood stem-cell support and concurrent chest radiotherapy in small cell lung cancer: a phase I/II trial.

Lung Cancer 2002 Jun;36(3):321-6

Institute of Medical Oncology, Radio-Oncology and Haematology, Inselspital, University of Berne, 3010 Berne, Switzerland.

View Article

Download full-text PDF

Source
June 2002